SFI
PDSB icon

Susquehanna Fundamental Investments’s PDS Biotechnology PDSB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,732
Closed -$44K – 1576
2020
Q3 		$44K Buy
+18,732
New +$52.5K ﹤0.01% 1324

Other funds holding PDSB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Susquehanna Fundamental Investments's PDSB Position: Q4 2020 in Review

Susquehanna Fundamental Investments sold out of PDS Biotechnology (PDSB) in Q4 2020, closing a stake of 18,732 shares — an estimated $44K sold.

Susquehanna Fundamental Investments first reported a position in PDSB in Q3 2020 and held it in 1 quarter. The position peaked at $44K in Q3 2020. 30 funds tracked by Wall St. Rank hold PDSB as of Q4 2020.

  • Susquehanna Fundamental Investments reported no remaining PDS Biotechnology position as of Q4 2020 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 18,732 PDS Biotechnology shares in Q4 2020, an estimated $44K.
  • Susquehanna Fundamental Investments first reported a position in PDS Biotechnology in Q3 2020 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's PDS Biotechnology position peaked at $44K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2020.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2020, filed 16 Feb 2021.